Evaluation of serum cystatin C levels and 99mTechnetium-mercaptoacetyltriglycine-3 renal scintigraphy for the early detection of cisplatin-induced renal toxicity in cancer patients

Nephrology

Volumn 7, Issue 2, 2002, Pages 56-60

  Günel, Nazan ^a,c   Coskun, Ugur ^a   Yamaç, Deniz ^a   Abamor, Evrim ^a   Demirtas, Selda ^b   Atasever, Tamer ^a   Karaca, Levent ^b  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

99mTechnetium mercaptoacetyltriglycine 3 scintigraphy; Cisplatin; Cystatin C; Nephrotoxicity

Indexed keywords

CISPLATIN; CREATININE; CYSTATIN C; MERTIATIDE TC 99M;

ADULT; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; DRUG EFFECT; EARLY DIAGNOSIS; FEMALE; HUMAN; KIDNEY SCINTISCANNING; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

EID: 0036050128     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2002.00082.x     Document Type: Article

References (34)

1. High dose cisplatin therapy in ovarian cancer
2. Renal and electrolyte disturbances associated with cisplatin
3. Cisplatin nephrotoxicity in a patient with a single kidney
4. Newer insights into cisplatin nephrotoxicity
5. Human γ-trace, a basic microprotein aminoacid sequence and presence in the adenohypophysis
6. Structure and expression of the human cystatin C gene
7. Determination of serum cystatin C in patients with essential hypertension
8. A promising marker of glomerular filtration rate to replace creatinine
9. Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine
10. Cystatin C measurement and its practical use in patients with various renal diseases
11. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinin for glomerular filtration rate
12. 2 -microglobulin/cystatin C ratio
13. Technetium-99m (99m Tc) mercaptoacetyltriglycine: Update on the new 99m Tc renal tubuler function agent
14. Pharmacokinetics of technetium-99m-MAG3 in humans
15. Clinical applications of renal scintigraphy
16. Radionuclide Renography: A personal approach
17. Comperative nephrotoxicity of tetraplatin and cisplatin in rats
18. Comparison of Tc-99m MAG3 with iodine-31 hippuran by a simultaneous dual channel technique
19. Renal artery stenosis and ischemia: Effect on renal blood flow and extraction fraction
20. 99mTc-DTPA
21. Clinical value of cystatin C determination
22. Biological variation of cystatin C: Implications for the assesment of the glomerular filtration rate
23. The blood serum concentration of cystatin C (γ-trace) as measure of glomerular filtration rate
24. 2-microglobulin as a measure of glomerular filtration rate
25. Diagnostic value of analysis of cystatin C and protein HC in biological fluids
26. Improved prediction of decreased creatinin clearance by serum cystatin C use in cancer patients before and during chemotherapy
27. Quantitation of renal parechymal retention of Tc-99m MAG3 in renal transplants
28. Renal kinetics in transplants with chronic rejection and renal artery stenosis are similar
29. Acute cisplatin nephrotoxicity in the rat: Evidence for impaired entry of sodium into proximal tubule cells
30. Effects of high-dose cisplatin on glomerular function in the human kidney
31. Acute effect of cisplatin on renal hemodynamics and tubular function in dog kidneys
32. Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats
33. Renal complications of cytotoxic therapy
34. Comparison of methods of evaluating nephrotoxicity of cis-platinum